These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

307 related articles for article (PubMed ID: 15800324)

  • 1. Combining gemcitabine and capecitabine in patients with advanced biliary cancer: a phase II trial.
    Knox JJ; Hedley D; Oza A; Feld R; Siu LL; Chen E; Nematollahi M; Pond GR; Zhang J; Moore MJ
    J Clin Oncol; 2005 Apr; 23(10):2332-8. PubMed ID: 15800324
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expanded phase II trial of gemcitabine and capecitabine for advanced biliary cancer.
    Riechelmann RP; Townsley CA; Chin SN; Pond GR; Knox JJ
    Cancer; 2007 Sep; 110(6):1307-12. PubMed ID: 17628484
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gemcitabine, 5-fluorouracil, and leucovorin in advanced biliary tract and gallbladder carcinoma: a North Central Cancer Treatment Group phase II trial.
    Alberts SR; Al-Khatib H; Mahoney MR; Burgart L; Cera PJ; Flynn PJ; Finch TR; Levitt R; Windschitl HE; Knost JA; Tschetter LK
    Cancer; 2005 Jan; 103(1):111-8. PubMed ID: 15558814
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A phase II study of gemcitabine and capecitabine in advanced cholangiocarcinoma and carcinoma of the gallbladder: a single-institution prospective study.
    Iyer RV; Gibbs J; Kuvshinoff B; Fakih M; Kepner J; Soehnlein N; Lawrence D; Javle MM
    Ann Surg Oncol; 2007 Nov; 14(11):3202-9. PubMed ID: 17705089
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Capecitabine combined with gemcitabine (CapGem) as first-line treatment in patients with advanced/metastatic biliary tract carcinoma.
    Cho JY; Paik YH; Chang YS; Lee SJ; Lee DK; Song SY; Chung JB; Park MS; Yu JS; Yoon DS
    Cancer; 2005 Dec; 104(12):2753-8. PubMed ID: 16294346
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Advanced biliary tract carcinomas: a retrospective multicenter analysis of first and second-line chemotherapy.
    Fiteni F; Jary M; Monnien F; Nguyen T; Beohou E; Demarchi M; Dobi E; Fein F; Cleau D; Fratté S; Nerich V; Bonnetain F; Pivot X; Borg C; Kim S
    BMC Gastroenterol; 2014 Aug; 14():143. PubMed ID: 25117717
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A phase II study of capecitabine and oxaliplatin combination chemotherapy in patients with inoperable adenocarcinoma of the gall bladder or biliary tract.
    Graham JS; Boyd K; Coxon FY; Wall LR; Eatock MM; Maughan TS; Highley M; Soulis E; Harden S; Bützberger-Zimmerli P; Evans TR
    BMC Res Notes; 2016 Mar; 9():161. PubMed ID: 26969121
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A phase II trial of gemcitabine and capecitabine in patients with unresectable or metastatic gallbladder cancer or cholangiocarcinoma: Southwest Oncology Group study S0202.
    Iqbal S; Rankin C; Lenz HJ; Gold PJ; Ahmad SA; El-Khoueiry AB; Messino MJ; Holcombe RF; Blanke CD
    Cancer Chemother Pharmacol; 2011 Dec; 68(6):1595-602. PubMed ID: 21556747
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Three-weekly oxaliplatin combined with gemcitabine and capecitabine in the first-line treatment of patients with advanced biliary tract cancer.
    Petrioli R; Roviello G; Fiaschi AI; Laera L; Roviello F; Marrelli D; Francini E
    Anticancer Drugs; 2015 Jul; 26(6):682-6. PubMed ID: 25811963
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Phase II study of capecitabine combined with gemcitabine in patients with advanced gallbladder carcinoma.
    Cho JY; Nam JS; Park MS; Yu JS; Paik YH; Lee SJ; Lee DK; Yoon DS
    Yonsei Med J; 2005 Aug; 46(4):526-31. PubMed ID: 16127778
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Patient-reported outcomes of patients with advanced biliary tract cancers receiving gemcitabine plus capecitabine: a multicenter, phase II trial of the Swiss Group for Clinical Cancer Research.
    Koeberle D; Saletti P; Borner M; Gerber D; Dietrich D; Caspar CB; Mingrone W; Beretta K; Strasser F; Ruhstaller T; Mora O; Herrmann R;
    J Clin Oncol; 2008 Aug; 26(22):3702-8. PubMed ID: 18669455
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A phase II trial of gemcitabine plus capecitabine for metastatic renal cell cancer previously treated with immunotherapy and targeted agents.
    Tannir NM; Thall PF; Ng CS; Wang X; Wooten L; Siefker-Radtke A; Mathew P; Pagliaro L; Wood C; Jonasch E
    J Urol; 2008 Sep; 180(3):867-72; discussion 872. PubMed ID: 18635226
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phase II study of capecitabine plus cisplatin as first-line chemotherapy in advanced biliary cancer.
    Kim TW; Chang HM; Kang HJ; Lee JR; Ryu MH; Ahn JH; Kim JH; Lee JS; Kang YK
    Ann Oncol; 2003 Jul; 14(7):1115-20. PubMed ID: 12853355
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gemcitabine-based chemotherapy for advanced biliary tract carcinomas.
    Abdel-Rahman O; Elsayed Z; Elhalawani H
    Cochrane Database Syst Rev; 2018 Apr; 4(4):CD011746. PubMed ID: 29624208
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fluoropyrimidines plus cisplatin versus gemcitabine/gemcitabine plus cisplatin in locally advanced and metastatic biliary tract carcinoma - a retrospective study.
    Croitoru A; Gramaticu I; Dinu I; Gheorghe L; Alexandrescu S; Buica F; Luca I; Becheanu G; Herlea V; Simionov I; Hrehoret D; Lupescu I; Popescu I; Diculescu M
    J Gastrointestin Liver Dis; 2012 Sep; 21(3):277-84. PubMed ID: 23012669
    [TBL] [Abstract][Full Text] [Related]  

  • 16. SWOG S0809: A Phase II Intergroup Trial of Adjuvant Capecitabine and Gemcitabine Followed by Radiotherapy and Concurrent Capecitabine in Extrahepatic Cholangiocarcinoma and Gallbladder Carcinoma.
    Ben-Josef E; Guthrie KA; El-Khoueiry AB; Corless CL; Zalupski MM; Lowy AM; Thomas CR; Alberts SR; Dawson LA; Micetich KC; Thomas MB; Siegel AB; Blanke CD
    J Clin Oncol; 2015 Aug; 33(24):2617-22. PubMed ID: 25964250
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gemcitabine concurrent with continuous infusional 5-fluorouracil in advanced biliary cancers: a review of the Princess Margaret Hospital experience.
    Knox JJ; Hedley D; Oza A; Siu LL; Pond GR; Moore MJ
    Ann Oncol; 2004 May; 15(5):770-4. PubMed ID: 15111345
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phase II trial of combination chemotherapy with gemcitabine, 5-fluorouracil and cisplatin for advanced cancers of the bile duct, gallbladder, and ampulla of Vater.
    Sohn BS; Yuh YJ; Kim KH; Jeon TJ; Kim NS; Kim SR
    Tumori; 2013; 99(2):139-44. PubMed ID: 23748804
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biweekly high-dose gemcitabine alone or in combination with capecitabine in patients with metastatic pancreatic adenocarcinoma: a randomized phase II trial.
    Scheithauer W; Schüll B; Ulrich-Pur H; Schmid K; Raderer M; Haider K; Kwasny W; Depisch D; Schneeweiss B; Lang F; Kornek GV
    Ann Oncol; 2003 Jan; 14(1):97-104. PubMed ID: 12488300
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Radiochemotherapy followed by gemcitabine and capecitabine in extrahepatic bile duct cancer: a phase I/II trial.
    Schoppmeyer K; Miethe S; Wiedmann M; Liebmann A; Hauss J; Mossner J; Caca K; Witzigmann H; Hildebrandt G
    Am J Clin Oncol; 2006 Dec; 29(6):576-82. PubMed ID: 17148994
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.